The impact of COVID-19 vaccinations in immunocompromised adult patients is unknown. However, as long as


Key Highlights :

1. The study found that adult patients who received the recommended two doses of COVID-19 vaccine (against both Middle East respiratory syndrome coronavirus and severe acute respiratory syndrome coronavirus) were more likely to have higher levels of antibodies against COVID-19 than patients who only received one dose.
2. The study authors suggest that adults who receive the recommended two doses of COVID-19 vaccine may be more likely to experience adequate protection against COVID-19 if they are immunocompromised.


\tThe study found that adult patients who received the recommended two doses of COVID-19 vaccine (against both Middle East respiratory syndrome coronavirus and severe acute respiratory syndrome coronavirus) were more likely to have higher levels of antibodies against COVID-19 than patients who only received one dose. \tThe study authors suggest that adults who receive the recommended two doses of COVID-19 vaccine may be more likely to experience adequate protection against COVID-19 if they are immunocompromised.

Continue Reading at Source : news-medical
Previous Post Next Post